Comparative Investigation on the in vitro susceptibility of Propionibacterium acnes (P. acnes) against nadifloxacin, erythromycin, clindamycin and tetracycline

Comparative Investigation on the in vitro susceptibility of Propionibacterium acnes (P. acnes) against nadifloxacin, erythromycin, clindamycin and tetracycline - P343

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00014231

Enrollment

180

Registered

2018-03-02

Start date

2018-03-05

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L70.0

Interventions

Group 1: Clinical Isolates of approximately 180 patients suffering from Acne vulgaris will be collected. Therefore, at one time a swab of one pustule will be obtained per Patient. The samples will be

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Acne vulgaris in facial area

Exclusion criteria

Exclusion criteria: laboratory study, therefore no exclusion criteria defined

Design outcomes

Primary

Measure	Time frame
Laboratory study, patients will not be treated, solely collection of Skin swabs - therefore no Primary outcome is defined.	—

Secondary

Measure	Time frame
see Explanation Primary outcome	—

Countries

Germany

Contacts

Public ContactClaudia Neumeister

Dr. R. Pfleger GmbH

claudia.neumeister@dr-pfleger.de0951/6043-0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026